DeutschNewstral
Article
Forbes on 2018-03-23 14:05
How 23andMe Quelled FDA Concerns About DTC Breast Cancer Gene Test
Related news
- FDA Clears 23AndMe's DTC Breast Cancer Gene Test -- But 'Buyer Beware'Forbes
23andMe Relaunches Gene Testwsj.com
23andMe gets FDA approval to report breast cancer risk without a doctorSan Jose Mercury News
23andMe gets FDA approval for at-home breast cancer risk testwtnh.com
Test risk of breast cancer from home with new FDA-approved DNA kit by 23andMeKING 5- CFDA OKs carrier screening test from 23andMecontracostatimes.com
23andMe Will Now Test for BRCA Breast-Cancer GenesThe Atlantic- C23andMe returns with FDA-approved genetic health testscontracostatimes.com
FDA grants 23andMe approval to test for rare genetic conditionThe Verge
23andMe Will Let You Test For Risk of Breast CancerNBC Bay Area- FDA approves gene therapy drugKING 5
23andMe gets FDA green light for cancer risk testTechCrunch
FDA clears 23andMe to warn you about potential health risksengadget
23andMe reboots genetic health testing, now with FDA approvalArs Technica- FDA Clears 23andMe For All Health and Carrier Traits TestingTechCrunch
- FDA Authorizes 23andMe to Market Genetic Testing For Bloom SyndromeTechCrunch